Product Name

  • Name

    N,N-Dimethylformamide

  • EINECS 200-679-5
  • CAS No. 68-12-2
  • Article Data258
  • CAS DataBase
  • Density 0.884 g/cm3
  • Solubility soluble in water
  • Melting Point -61 °C
  • Formula C3H7NO
  • Boiling Point 153 °C at 760 mmHg
  • Molecular Weight 73.0947
  • Flash Point 57.8 °C
  • Transport Information UN 2265 3/PG 3
  • Appearance Clear colorless liquid
  • Safety 53-45
  • Risk Codes 61-20/21-36
  • Molecular Structure Molecular Structure of 68-12-2 (N,N-Dimethylformamide)
  • Hazard Symbols ToxicT
  • Synonyms DMF;DMF(amide);DMFA;Dimethylformamide;Formamide,N,N-dimethyl-;N,N-Dimethylmethanamide;N-Formyldimethylamine;NSC5356;Virodene-P 058;
  • PSA 20.31000
  • LogP 0.34030

N,N-Dimethylformamide Specification

The N,N-Dimethylformamide, with the CAS registry number 68-12-2, is also known as Dimethyl formamide; Formyldimethylamine; DMF; DMFA. It belongs to the product categories of Organics;LEDA HPLC;Dimethylformamide (DMF).This chemical's molecular formula is C3H7NO and molecular weight is 73.09. What's more,Its systematic name is N,N-Dimethylformamide.It is a Clear colorless liquid.Slightly less dense than water. Vapors heavier than air. Toxic by inhalation or skin absorption. May irritate eyes,skin and nose,May cause nausea.When you use it,Avoid exposure - obtain special instruction before use.In case of accident or if you feel unwell, seek medical advice immediately (show label where possible).

Physical properties about N,N-Dimethylformamide are:
(1)ACD/LogP:  -0.829; (2)# of Rule of 5 Violations:  0; (3)ACD/LogD (pH 5.5):  -0.83; (4)ACD/LogD (pH 7.4):  -0.83; (5)ACD/BCF (pH 5.5):  1.00; (6)ACD/BCF (pH 7.4):  1.00; (7)ACD/KOC (pH 5.5):  8.43; (8)ACD/KOC (pH 7.4):  8.43; (9)#H bond acceptors:  2; (10)#H bond donors:  0; (11)#Freely Rotating Bonds:  0; (12)Index of Refraction:  1.396; (13)Molar Refractivity:  19.856 cm3; (14)Molar Volume:  82.628 cm3; (15)Surface Tension:  25.7189998626709 dyne/cm; (16)Density:  0.885 g/cm3; (17)Flash Point:  57.778 °C; (18)Enthalpy of Vaporization:  38.98 kJ/mol; (19)Boiling Point:  152.999 °C at 760 mmHg; (20)Vapour Pressure:  3.40300011634827 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES:CN(C)C=O;
(2)Std. InChI:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3;
(3)Std. InChIKey:ZMXDDKWLCZADIW-UHFFFAOYSA-N.

The toxicity data of N,N-Dimethylformamide as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 intraperitoneal 500mg/kg (500mg/kg) LIVER: OTHER CHANGES

KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION

BLOOD: CHANGES IN CELL COUNT (UNSPECIFIED)		 British Journal of Industrial Medicine. Vol. 13, Pg. 51, 1956.
dog LD50 intravenous 470mg/kg (470mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965.
guinea pig LD50 intravenous 1050mg/kg (1050mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965.
guinea pig LDLo intraperitoneal 4gm/kg (4000mg/kg) LIVER: FATTY LIVER DEGERATION American Industrial Hygiene Association Journal. Vol. 35, Pg. 21, 1974.
mouse LC50 inhalation 9400mg/m3/2H (9400mg/m3) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. Vol. 1, Pg. 54, 1961.
mouse LD50 intramuscular 3900mg/kg (3900mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965.
mouse LD50 intraperitoneal 650mg/kg (650mg/kg)   Cancer Chemotherapy Reports. Vol. 30, Pg. 9, 1963.
mouse LD50 intravenous 2500mg/kg (2500mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965.
mouse LD50 oral 2900mg/kg (2900mg/kg)   National Technical Information Service. Vol. OTS0521148,
mouse LD50 subcutaneous 4500mg/kg (4500mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965.
rabbit LD50 intraperitoneal 1gm/kg (1000mg/kg) LIVER: OTHER CHANGES

BLOOD: CHANGES IN CELL COUNT (UNSPECIFIED)

KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION		 British Journal of Industrial Medicine. Vol. 13, Pg. 51, 1956.
rabbit LD50 intravenous 1800mg/kg (1800mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965.
rabbit LD50 oral 5gm/kg (5000mg/kg)   National Technical Information Service. Vol. OTS0520699,
rabbit LD50 skin 4720mg/kg (4720mg/kg)   American Industrial Hygiene Association Journal. Vol. 30, Pg. 470, 1969.
rat LCLo inhalation 5000ppm/6H (5000ppm)   United States Patent Document. Vol. #5122301,
rat LD skin > 3160mg/kg (3160mg/kg)   National Technical Information Service. Vol. OTS0516779,
rat LD50 intraperitoneal 1400mg/kg (1400mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: MUSCLE WEAKNESS		 British Journal of Industrial Medicine. Vol. 13, Pg. 51, 1956.
rat LD50 intravenous 2gm/kg (2000mg/kg)   Zeitschrift fuer Krebsforschung. Vol. 69, Pg. 103, 1967.
rat LD50 oral 2800mg/kg (2800mg/kg)   Zeitschrift fuer Krebsforschung. Vol. 69, Pg. 103, 1967.
rat LD50 subcutaneous 3800mg/kg (3800mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965.
rat LD50 unreported > 3gm/kg (3000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 645, 1968.

Related Products

Hot Products

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View